Literature DB >> 27515871

Effect of the Spiritist "passe" energy therapy in reducing anxiety in volunteers: A randomized controlled trial.

Ricardo de Souza Cavalcante1, Vanessa Burgugi Banin2, Niura Aparecida de Moura Ribeiro Paula3, Solange Ramires Daher4, Marta Cassoni Habermann5, Francisco Habermann6, Ariane Moyses Bravin7, Carlos Eduardo Capelasso da Silva8, Luis Gustavo Modelli de Andrade9.   

Abstract

BACKGROUND: In Brazil, one of the most used energy therapies is the Spiritist "passe", which is practiced by Spiritist healers. Although experimental studies have demonstrated the effectiveness of different energy therapies in reducing anxiety and pain, little is known about the effect of the Spiritist "passe" on health outcomes. Therefore, the present study aimed at evaluating the effectiveness of "passe" energy therapy in reducing anxiety symptoms. METHODS/
DESIGN: In this prospective, randomized controlled trial, participants were randomly allocated into two groups: Intervention (8 weekly Spiritist "passe" sessions, n=23), and Control (8 weekly sham Spiritist "passe" sessions, n=27). Anxiety was assessed using the Trait Anxiety Inventory (STAI-trait).
RESULTS: Of 97 individuals screened, 50 were included in the final analysis. Decreasing STAI-trait anxiety scores were observed in both groups throughout the study (p<0.0001). By the end of the study, 17% and 63% of intervention and control participants, respectively, still met the criterion for anxiety (p=0.001). However, anxiety reduction was more accentuated in the Spiritist "passe" group (p=0.02).
CONCLUSION: In this small pilot study, anxiety was more markedly reduced in participants receiving the Spiritist "passe" than in controls, warranting larger trials. TRIAL REGISTRATION: NCT02376959.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Complementary therapies; Energy therapies; Spiritism; Spiritual healing; Therapeutic touch

Mesh:

Year:  2016        PMID: 27515871     DOI: 10.1016/j.ctim.2016.05.002

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446



北京卡尤迪生物科技股份有限公司 © 2022-2023.